)
Edge20 Mar 2026
Tetra Pak: The Shape of Innovation
The story of Tetra Pak, the Rausing family, and how a paper tetrahedron gave rise to a company that now delivers almost 180 billion packages a year.
Cyclopharm
Cyclopharm (CYC) investor relations material
Cyclopharm H2 2025 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.H2 2025 earnings summary24 Feb, 2026
Executive summary
Achieved record group revenue of A$32.3 million for 2025, up 17% year-over-year, driven by US market entry and strong third-party distribution growth.
US became the largest individual country for Technegas® sales, with revenue of $2.7 million, up 226% year-over-year.
Loss after tax increased to $17.2 million from $13.2 million, reflecting targeted investment in US expansion.
Technegas® now operational in 67 countries, with Colombia added in 2025.
Financial highlights
Total revenue: $32.3 million (2024: $27.6 million), up 17.2% year-over-year.
Technegas® revenue: $16.7 million, up 9.7%; third-party distribution revenue: $15.6 million, up 26.5%.
Underlying EBITDA loss: $15.4 million (2024: $11.9 million), up 28.9%.
Gross margin: $17.9 million, stable year-over-year, with margin pressure from lower-margin third-party sales.
Diluted loss per share: (15.64) cents (2024: (12.83) cents).
Outlook and guidance
Reaffirmed guidance for 250–300 revenue-generating Technegas® sites in the US by H2 2026.
US market expected to drive exponential growth, with Beyond PE initiatives targeting broader respiratory applications.
Total addressable market estimated at over US$1 billion annually, combining US PE and Beyond PE opportunities.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Cyclopharm
- Record revenue and US expansion drive strong recurring growth and global market leadership.CYC
Investor Update26 Dec 2025 - Record revenue growth and USA expansion drive outlook, with guidance reaffirmed.CYCH1 202520 Oct 2025
- US reimbursement and first sales fuel Technegas demand and global expansion prospects.CYCH1 202413 Jun 2025
- Record sales and US expansion drive growth, despite higher net loss from investment.CYCH2 20245 Jun 2025
Next Cyclopharm earnings date
H1 20261 Sep, 2026
Cyclopharm
Next Cyclopharm earnings date
H1 20261 Sep, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage